Create a narrative

Tempus AI Community

NasdaqGS:TEM Community

1 Narratives written by author
0 Comments on narratives written by author
135 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

AstraZeneca And Pathos Partnership Will Expand Precision Medicine

Key Takeaways Pharma partnerships and the shift toward AI-driven precision medicine are fueling strong, high-margin revenue growth and expanding Tempus' competitive opportunities. Integration of new platforms and data assets strengthens product differentiation, increases client retention, and accelerates the shift to high-margin software and data contracts.

US$65.50

FV

4.3% overvalued

36.12%

Revenue growth p.a.

0

0

85

5 days ago